Examples of 'agent binds' in a sentence
Meaning of "agent binds"
agent binds: This phrase refers to an intermediary or representative who creates a formal or legal agreement between parties, establishing a binding contract or relationship
How to use "agent binds" in a sentence
Basic
Advanced
agent binds
The second agent binds GHb.
Then the agent binds to tissues that produce corresponding antigens, such as PSA or hK2.
In step a, the solubilising agent binds to an anion exchange resin.
The composition of claim 2 wherein said first agent binds to Smo.
A specific binding agent binds substantially only to a particular target.
In some embodiments a binding agent binds to C3d.
The binding agent binds preferentially to the specified polypeptide.
For example, the sequestering agent binds to a metal cation.
The first agent binds hemoglobin forming a first detectable complex.
In certain embodiments, the agent binds a human RSPO protein.
The drying agent binds water from various sources.
In another preferred example, the TNAP binding agent binds specifically to BAP.
A specific binding agent binds substantially only to a defined target.
In some embodiments, the additional therapeutic agent binds to FKBP12.
The chelating agent binds up the metal ions on the fruit and vegetable surfaces.
See also
In one preferred example, however, the TNAP binding agent binds to BAP.
In one embodiment said binding agent binds to the first extracellular loop of CLDN.
The method of example G22, wherein the additional therapeutic agent binds HPTP-beta.
Preferably, the ligand or agent binds specifically to homoarginine.
The drying agent binds the water and by-products by physical means.
Optionally, the method also includes determining whether the agent binds a polypeptide including SEQ ID NO, 18.
The selective agent binds to either TRBC1 or TRBC2 in a mutually exclusive manner.
Preferably, the ligand or agent binds specifically to BNP.
Preferably, such an agent binds to a polypeptide as disclosed herein.
In certain embodiments, the agent binds a human LGR protein.
Preferably, such an agent binds to a polypeptide of the present invention.
Preferably, the ligand or agent binds specifically to the polypeptide.
Preferably, the binding agent binds to the detectable entity in a stoichiometric fashion.
Preferably, the binding agent or agent binds specifically to the peptide or polypeptide.
Preferably, the ligand or agent binds specifically to the natriuretic peptide.
In another embodiment, the agent binds to a receptor of a type 1 interferon or IFNa.
Preferably, the ligand or agent binds specifically to the peptide or polypeptide.
Preferably, the ligand or agent binds specifically to the polypeptide as referred to herein.
In a specific embodiment, the agent binds specifically to a cancer stem cell antigen.
Preferably, the ligand or agent binds specifically to the peptide derived from preproBNP.
In an embodiment, said therapeutic agent binds the cMET protein and / or inhibits its biological activity.
Preferably, a Seprase binding agent binds to Seprase expressed on the cell surface.
In one embodiment, the agent binds to and neutralizes IFN or IFNa activity.
A method of any of claims 1-5, wherein the agent binds to a cytoplasmic portion of the receptor.
In one embodiment the Therapeutic Agent binds to and agonizes signal transduction through the B7-H7.
In some embodiments, such an agent binds to a target ( e.g., protein ) located on a cell surface.
In another embodiment, the cadherin-11 inhibitory agent binds selectively to a cadherin-11 counter receptor.
In one embodiment said binding agent binds to an extracellular domain of CLDN18.2.
In another embodiment the Therapeutic Agent binds to native B7-H7 and blocks binding to B7-H7CR.
